Vaccination in Individuals with Multiple Sclerosis - Part II

Creative Commons License

Tuncer A., Cinar B. P., BİLGE N., BÜNÜL S. D., Gozubatik-Celik R. G., Ciftci E. D., ...More

TURKISH JOURNAL OF NEUROLOGY, vol.29, no.2, pp.85-94, 2023 (ESCI) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 29 Issue: 2
  • Publication Date: 2023
  • Doi Number: 10.4274/tnd.2023.16984
  • Journal Name: TURKISH JOURNAL OF NEUROLOGY
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, CINAHL, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.85-94
  • Open Archive Collection: AVESIS Open Access Collection
  • Istanbul University Affiliated: No

Abstract

Multiple sclerosis (MS) is an autoimmune and demyelinating disease of the central nervous system. It is a chronic disease, and in the evaluation of all other health and vital processes, decisions about vaccination should be made considering the disease process and the medications used by the patient. Since vaccination can be performed at any stage of life, immune system activity should be reviewed in patients with MS except where it is characteristic of the vaccine. In this review, the applications of different vaccines in patients with MS are discussed in two separate sections (part 1 was published in the previous issue).